Reklāma
Repligen Q3 Results Top Estimates; Boosts FY23 Earnings Outlook
(RTTNews) - Life sciences company Repligen Corp. (RGEN) announced Tuesday third-quarter net income of $18.17 million or $0.32 per share, sharply down from $40.41 million or $0.71 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter was $0.23 per share, compared to $0.77 per share in the year-ago quarter.
Total revenues for the quarter decreased 30 percent to $141.19 billion from $200.74 billion in the same quarter last year.
On average, 13 analysts polled by Thomson Reuters expected the company to report earnings of $0.16 per share on revenues of $140.64 million for the quarter. Analysts' estimates typically exclude special items.
Looking ahead to fiscal 2023, the company now projects earnings in a range of $1.26 to $1.32 per share and adjusted earnings in a range of $1.70 to $1.76 per share on revenues between $635 million and $645 million.
Previously, the company expected earnings in the range of $1.00 to $1.08 per share and adjusted earnings in the range of $1.72 to $1.80 per share on revenues between $635 million and $645 million.
The Street is looking for earnings of $1.74 per share on revenues of $645.78 million for the year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Japan Retail Sales Climb 3.3% On Year In April
Japan Industrial Output Slips 0.9% In April
Win Streak May Continue For Singapore Stock Market
Japan Jobless Rate Holds Steady At 2.5%
Tokyo Overall Consumer Prices +3.4% On Year In May
Malaysia Stock Market Tipped To End Losing Streak
Mild Upside Seen For Japan Stock Market
